A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation

Stopped This was a strategic business decision. There were no safety concerns contributing to this decision.

Conditions

• Advanced Solid Tumors

Interventions

• DRUG: INCB099280
• DRUG: adagrasib

Sponsor

Incyte Corporation

Collaborators

• [object Object]